All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II Neurogenesis during Development and in the Adult Brain (joint with Transcriptional and Epigenetic Control in Stem Cells) $35,000
American Association of Blood Banks Dr. Naynesh R. Kamani Conference II 14th International Cord Blood Symposium: Give Life Twice $15,000
University of California, San Diego Prof. John M. Ravits Conference II California ALS Research Summit 2016 $11,400
Stanford University Dr. Joseph C. Wu Conference II Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
Gordon Research Conferences Dr. Ophir Klein MD, PhD Conference II 2016 Gordon Research Conference on Craniofacial Morphogenesis and Tissue Regeneration $5,000
City of Hope, Beckman Research Institute Fouad Kandeel Conference II 2016 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium $10,000
International Society for Experimental Hematology Dr. David Traver Conference II International Society for Experimental Hematology, 45th Annual Scientific Meeting $25,000
University of California, Los Angeles Mr. Donald B. Kohn Conference II Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop $29,807
Alliance Forum Foundation George Hara Conference II 2015 World Alliance Forum in San Francisco (2015 WAFSF) “Regenerative Medicine: Let’s Talk Business!” $10,000
Sanford Consortium for Regenerative Medicine Dr. Edward Holmes Conference II Stem Cell Meeting on the Mesa $50,000
University of California, Irvine Dr. Sidney Golub Conference II Human Research In Times of Controversy: From Stem Cells To Fetal Tissue $13,562
University of California, Davis Dr. Diana L. Farmer Clinical Trial Stage Projects The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele $8,996,477
Stanford University Dr. Reena Parada Thomas Clinical Trial Stage Projects Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme $11,999,991
City of Hope, Beckman Research Institute Elizabeth Budde Clinical Trial Stage Projects Phase I Study of Chimeric Antigen Receptor Engineered T Cells targeting CD33 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia $11,983,547
Regenerative Patch Technologies LLC Dr Jane S Lebkowski Clinical Trial Stage Projects A Phase 2b, Randomized, Assessor-Masked Clinical Trial to Assess the Safety and Efficacy of the CPCB-RPE1 Implant in Subjects with Geographic Atrophy $12,373,748
City of Hope, Beckman Research Institute Prof. John A Zaia Clinical Trial Stage Projects Evaluation of Safety and Feasibility of Cytomegalovirus-Specific, Anti-HIV Chimeric Antigen Receptor (CMV/HIV-CAR) T Cells in People with HIV $11,299,976
Combangio, Inc. R. Kim Brazzell Clinical Trial Stage Projects Phase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect $15,000,000
Immusoft Corporation Dr Robert Hayes Clinical Trial Stage Projects A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 $8,000,000
Eureka Therapeutics, Inc. Pei Wang Clinical Trial Stage Projects Autologous ARTEMIS® T Cells to Treat Refractory/Relapsed Pediatric Liver Cancer $10,600,072
Stanford University Dr. Matthew H Porteus Clinical Trial Stage Projects Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients $10,642,420
Angiocrine Bioscience, Inc. Dr. Paul Finnegan Clinical Trial Stage Projects AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205 $15,000,000
Genascence Corporation Dr. Thomas W Chalberg Jr. Clinical Trial Stage Projects A Phase 1b, Randomized, Blinded, Placebo-Controlled Dose-Ranging Study of GNSC-001 Evaluating Safety, Pharmacodynamics, and Biomarkers in Knee OA $11,637,194
Tachyon Therapeutics, Inc Ivan King Clinical Trial Stage Projects TACH101: A Potent, First-In-Class KDM4 Inhibitor for Advanced Cancers $7,141,843
City of Hope, Beckman Research Institute Ryotaro Nakamura Clinical Trial Stage Projects Treatment of Severe Aplastic Anemia by induction of mixed chimerism using CD4+ T cell depleted haploidentical donor stem cell transplant $9,054,216
Stanford University Alice Bertaina Clinical Trial Stage Projects Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant $11,998,188
Neurona Therapeutics Dr. Cory R Nicholas Clinical Trial Stage Projects Phase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy $7,999,999
Excision BioTherapeutics William Kennedy Clinical Trial Stage Projects Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy $6,852,486
Wake Forest University Health Sciences James Yoo Clinical Trial Stage Projects Phase I Treatment of Urethral Strictures in Humans $3,841,593
Stanford University Dr. Rosa Bacchetta Clinical Trial Stage Projects Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome $11,999,179
City of Hope, Beckman Research Institute Dr Jana Portnow Clinical Trial Stage Projects A Phase I Study of Multiple doses of NSC-Based Oncolytic Virotherapy Administered Intracerebrally to Patients with Recurrent High-Grade Gliomas $11,999,984
University of California, Davis Peter C Belafsky Clinical Trial Stage Projects A Double-Blind Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Progenitor Cells for the Treatment of Dysphagia $11,015,936
BioEclipse Therapeutics INC. Dr. Pamela Reilly Contag Clinical Trial Stage Projects PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS $7,999,689
Stanford University Dr. Joseph C. Wu Clinical Trial Stage Projects A Phase I, Pilot Study of Human Embryonic Stem Cell-Derived Cardiomyocytes in PaTients with ChrOnic Ischemic Left VentRicular Dysfunction (HECTOR) $6,987,507
Stanford University Crystal Mackall Clinical Trial Stage Projects Phase 1 Clinical Trial of Autologous GD2 Chimeric Antigen Receptor T Cells for Diffuse Intrinsic Pontine Gliomas and Spinal Diffuse Midline Glioma $11,998,310
Stanford University Dr. Matthew H Porteus Clinical Trial Stage Projects Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies. $10,563,822
Stanford University Dr. Gary Steinberg Clinical Trial Stage Projects Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects with Chronic Ischemic Subcortical Stroke $11,998,988
Cedars-Sinai Medical Center Clive Svendsen Clinical Trial Stage Projects CNS10-NPC-GDNF delivered into the motor cortex for the treatment of ALS $11,990,372
City of Hope, Beckman Research Institute Dr. Leo D Wang Clinical Trial Stage Projects Phase I Study of IL13Rα2-Targeting CAR T Cells After Lymphodepletion for Children with Refractory or Recurrent Malignant Brain Tumors $8,401,309
Immune-Onc Therapeutics Joseph Paul Woodard Clinical Trial Stage Projects Phase 1 Clinical Development of IO-202, A First-in-Class Antibody Targeting LILRB4, for the Treatment of AML with Monocytic Differentiation and CMML $6,000,000
University of California, Davis Dr. Diana L. Farmer Clinical Trial Stage Projects The CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair $8,996,474
Rocket Pharmaceuticals, Inc. Dr. Gayatri Rao Clinical Trial Stage Projects A Phase I Clinical Trial for a Lentiviral Gene Therapy Targeting the TCIRG1 Gene for Infantile Malignant Osteopetrosis (IMO) $1,010,000
University of California, San Francisco Steven G. Deeks Clinical Trial Stage Projects Anti-HIV duoCAR-T cell therapy for HIV infection $8,970,732
Brain Neurotherapy Bio Krystof S. Bankiewicz Clinical Trial Stage Projects A Phase 1b Safety Study for MRI guided delivery of AAV2-GDNF for the treatment of Parkinson’s disease $5,510,462
University of California, Los Angeles Dr. Sophie X Deng Clinical Trial Stage Projects Safety and Feasibility of Cultivated Autologous Limbal Stem Cells for Limbal Stem Cell Deficiency $10,301,486
Cedars-Sinai Medical Center Clive Svendsen Clinical Trial Stage Projects Clinical Study to Assess Safety and Efficacy of Subretinal Injection of Human Neural Progenitor Cells for Treatment of Retinitis Pigmentosa $10,444,063
City of Hope, Beckman Research Institute Dr Saul J Priceman Clinical Trial Stage Projects A Phase I Study of Chimeric Antigen Receptor Engineered Stem/Memory T Cells for the Treatment of HER2-Positive Brain Metastases $9,015,149
Rocket Pharmaceuticals, Inc. Dr. Kinnari Patel Clinical Trial Stage Projects LADICell $5,867,085
University of California, San Diego Dr. Stephanie Cherqui Clinical Trial Stage Projects Phase 1/2 study for autologous human CD34+ hematopoietic stem cells ex vivo transduced with pCCL-CTNS lentiviral vector for treatment of Cystinosis. $11,999,944
jCyte, Inc Henry John Klassen Clinical Trial Stage Projects A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects with Retinitis Pigmentosa $6,608,592
University of California, San Francisco Peter Stock Clinical Trial Stage Projects Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Diabetes in the Intra-Muscular Site: PARADIGM $11,083,012
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 28